|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01244 3D MEDICINES
Nominal 
0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 634,949 | 11.907% | 567,392 | 60,260 | 0 |
| Cost of Sales | (49,091) | 16.288% | (42,215) | (4,277) | -- |
| Gross Profit | 585,858 | 11.554% | 525,177 | 55,983 | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 837 | -- | (658,330) | (954,872) | (319,232) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (562,466) | -46.535% | (1,052,030) | (1,461,825) | (635,380) | |
| Taxation | (55) | -- | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 37,824 | 36.647% | 27,680 | 27,733 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (524,697) | -48.778% | (1,024,350) | (1,434,092) | (635,380) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,241 | -- | (4,097) | (3,974) | 6,448 |
| Depreciation & Amortisation | 25,461 | 17.875% | 21,600 | 12,591 | 3,371 |
| Directors' Emoluments | 288,558 | 176.452% | 104,379 | 79,673 | 1,300 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -230.000 | -89.787% | -2,252.000 | -3,672.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.632) | -- | (6.129) | (9.656) | -- |
| NBV per share ($) | 3.628 | -- | 3.689 | -- | -- |
| Remarks: | Real time quote last updated: 24/12/2024 07:42 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -103,509,000 |
| %Change | -42.007% |
| EPS / (LPS) | RMB -0.420 |
| NBV Per Share (¥) | RMB 3.284 |